Remove Doctors Remove FDA Remove Government Remove Prescription
article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The FDA needs to study what people do when they see a DTC ad. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. Still, the gatekeeper continues to be their doctor.

Marketing 285
article thumbnail

Dr. B: Expanding the business model from COVID vaccines to antiviral medications

pharmaphorum

As the pandemic progressed, the platform evolved to meet other needs that have materialised within the healthcare sector, including recently unveiling its “Visitless Prescriptions” service. “We are currently focused on offering a convenient way to get prescriptions. Both drugs are accessible via prescription only.

Medical 92
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dr B raises $8m for telehealth service to deliver COVID antivirals

pharmaphorum

The cash injection will be used to launch a telehealth service that promises to provide prescriptions and services to patients regardless of their ability to pay. The “visitless prescription” service will be available for free for people with low incomes, according to Dr B’s website.

article thumbnail

Psychedelic medicines: are they gaining traction in Europe?

European Pharmaceutical Review

The Schedule 1 classification means that these substances cannot be administered by doctors and, though they may be used for the purposes of research a government licence is often required. These restrictions provide the first obstacles to scientific research and commercial development.

Medicine 113
article thumbnail

How to Work with Patient Advocates, Influencers, and Ambassadors

PM360

When asked how pharma companies could earn more trust from patients, lower drug prices and other financially supported access to treatment ranked as the top things patients would want to see along with more educational resources and support of government policies to protect patients’ rights. Different patients have unique needs.

article thumbnail

Race to the finish: pharma edges closer to approval with RSV vaccines

Pharmaceutical Technology

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. This would be preferable for patients as doctors must administer Synagis to patients five times per month during peak RSV season. per 100,000.

Pharma 64
article thumbnail

Uri Goren

Cadensee

It's become the main thing that the doctors are looking at now. And did you know at the time that you were a trailblazer in this space? It broke the confines of you being a doctor learning healthcare, learning to be a medical profession and that stayed there; it just broke it all. Interview Transcription (mild edits).